6 noninvasive assessment of liver fibrosis: serum markers and transient elastography (fibroscan) evaluación no invasiva de fibrosis hepática: marcadores séricos y elastografía transitoria (fibroscan)

7 higher anti-liver fibrosis effect of cordyceps militaris-fermented product cultured with deep ocean water via inhibiting proinflammatory factors and fibrosis-related factors expressions

8 therapeutic potential of amniotic-fluid-derived stem cells on liver fibrosis model in mice

9 double knockdown of phd1 and keap1 attenuated hypoxia-induced injuries in hepatocytes

10 insulin resistance, atherogenic disorders and liver fibrosis in patients with metabolic syndrome

11 hepatic expression of cannabinoid receptors cb1 and cb2 correlate with fibrogenesis in patients with chronic hepatitis b

12 liver fibrosis in treatment-naïve hiv-infected and hiv/hbv co-infected patients: zambia and switzerland compared

13 culture model of rat portal myofibroblasts

14 the best radiographic method for determining root canal morphology in mandibular first premolars: a study of chinese descendants in taiwan

15 development of a non-invasive model to improve the accuracy of determining liver fibrosis stage in nonalcoholic fatty liver disease

16 circulating mirnas as predictor markers for activation of hepatic stellate cells and progression of hcv-induced liver fibrosis

17 Antler stem cells as a novel stem cell source for reducing liver fibrosis.

18 Transient elastography for screening of liver fibrosis: cost-effectiveness analysis from six prospective cohorts in Europe and Asia.

19 Smooth Muscle α-actin Deficiency Leads to Decreased Liver Fibrosis via Impaired Cytoskeletal Signaling in Hepatic Stellate Cells.

20 siRNA- and miRNA-based therapeutics for liver fibrosis.

21 Liver fibrosis staging with combination of APRI and FIB-4 scoring systems in chronic hepatitis C as an alternative to transient elastography.

22 Parathyroid hormone-related protein activates HSCs via hedgehog signalling during liver fibrosis development

23 Reversal of established liver fibrosis by IC-2-engineered mesenchymal stem cell sheets

24 Adoptive Transfer of Bone Marrow-Derived Monocytes Ameliorates Schistosoma mansoni -Induced Liver Fibrosis in Mice

25 A variant in the MICA gene is associated with liver fibrosis progression in chronic hepatitis C through TGF-β1 dependent mechanisms

26 Development and validation of a primate model for liver fibrosis

27 Chronic exposure to tetrabromodiphenyl ether (BDE-47) aggravates hepatic steatosis and liver fibrosis in diet-induced obese mice

28 Docosahexaenoic acid inhibits hepatic stellate cell activation to attenuate liver fibrosis in a PPARγ-dependent manner

29 Wogonin attenuates liver fibrosis via regulating hepatic stellate cell activation and apoptosis

30 Characteristics of liver fibrosis associated with chronic Opisthorchis felineus infection in Syrian hamsters and humans

31 A liver fibrosis staging method using cross-contrast network

32 Locostatin Alleviates Liver Fibrosis Induced by Carbon Tetrachloride in Mice

33 A Novel Non-invasive Method for Predicting Liver Fibrosis by Quantifying the Hepatic Vein Waveform

34 Validation Study of Elastographies in Patients With Nonalcoholic Fatty Liver Disease for Detecting Liver Fibrosis

35 Liver Fibrosis and Metabolic Alterations in Adults With alpha-1-antitrypsin Deficiency Caused by the Pi*ZZ Mutation

36 Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis

37 Activated hepatic stellate cells and portal fibroblasts contribute to cholestatic liver fibrosis in MDR2 knockout mice

38 Resveratrol improves CCL4-induced liver fibrosis in mouse by upregulating endogenous IL-10 to reprogramme macrophages phenotype from M(LPS) to M(IL-4)

39 Novel cytisine derivatives exert anti-liver fibrosis effect via PI3K/Akt/Smad pathway

40 Exogenous Administration of Low-Dose Lipopolysaccharide Potentiates Liver Fibrosis in a Choline-Deficient <span style="font-variant: small-caps">l</span>-Amino-Acid-Defined Diet-Induced Murine Steatohepatitis Model

41 Deep learning with ultrasonography: automated classification of liver fibrosis using a deep convolutional neural network.

42 Liver Fibrosis Assessment with Diffusion-Weighted Imaging: Value of Liver Apparent Diffusion Coefficient Normalization Using the Spleen as a Reference Organ.

43 Cost-effectiveness of non-invasive screening for alcohol-related liver fibrosis.

44 Changes of liver fibrosis in chronic hepatitis C patients with no response to interferon-alpha therapy: including quantitative assessment by a morphometric method.

45 Extracellular matrix-penetrating nanodrill micelles for liver fibrosis therapy.

46 The diagnostic value of a globulin/platelet model for evaluating liver fibrosis in chronic hepatitis B patients

47 Liver fibrosis and CD206 macrophage accumulation are suppressed by anti-GM-CSF therapy.

48 A network pharmacology approach to investigating the mechanism of Tanshinone IIA for the treatment of liver fibrosis

49 influence of resveratrol on liver fibrosis induced by dimethylnitrosamine in male rats

50 hepatoprotective role of ethanolic extract of vitex negundo in thioacetamide-induced liver fibrosis in male rats

51 nanoparticles for the treatment of liver fibrosis

52 factors that could impact on liver fibrosis staging by transient elastography

53 sorafenib prevents liver fibrosis in a non-alcoholic steatohepatitis (nash) rodent model

54 thymoquinone restores liver fibrosis and improves oxidative stress status in a lipopolysaccharide-induced inflammation model in rats

55 cytokines and stats in liver fibrosis

56 bushen prescription in treatment of liver fibrosis and its role in regulating treg/th17 balance

57 ekstrak buah delima terstandar menurunkan derajat fibrosis hati pada hewan model tikus putih (standardized pomegranate fruit extract reduces liver fibrosis degree on albino rats (rattus norvegicus) as an animal model)

58 gamma-glutamyl transpeptidase-to-platelet ratio predicts significant liver fibrosis of chronic hepatitis b patients in china

59 corrigendum to “an increased ratio of glycated albumin to hba1c is associated with the degree of liver fibrosis in hepatitis b virus-positive patients”

60 Clinical Predictors of Liver Fibrosis in Patients With Chronic Hepatitis B Virus Infection From Children to Adults

61 Impacts of the Percentage of Basal Core Promoter Mutation on the Progression of Liver Fibrosis After Hepatitis B e Antigen Seroconversion

62 MRI Extracellular Volume Fraction in Liver Fibrosis-A Comparison of Different Time Points and Blood Pool Measurements.

Keyword Connections

Journals

Research Groups

Bibliographies